Growth Metrics

Catheter Precision (VTAK) Depreciation & Amortization (CF) (2017 - 2025)

Catheter Precision has reported Depreciation & Amortization (CF) over the past 9 years, most recently at $527000.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 0.75% to $527000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, changed 0.28% year-over-year, with the annual reading at $2.1 million for FY2025, 0.28% changed from the prior year.
  • Depreciation & Amortization (CF) was $527000.0 for Q4 2025 at Catheter Precision, roughly flat from $528000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.4 million in Q1 2023 and troughed at -$406000.0 in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $518500.0 (2023), against an average of $414250.0.
  • The largest YoY upside for Depreciation & Amortization (CF) was 1968.0% in 2023 against a maximum downside of 398.53% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $315000.0 in 2021, then plummeted by 92.06% to $25000.0 in 2022, then surged by 1968.0% to $517000.0 in 2023, then increased by 2.71% to $531000.0 in 2024, then fell by 0.75% to $527000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Depreciation & Amortization (CF) are $527000.0 (Q4 2025), $528000.0 (Q3 2025), and $529000.0 (Q2 2025).